Selected Reading
- Arbeit RD et al: Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 2:85, 1984
- Baker CJ, Edwards MS: Group B streptococcal infections. In Infectious Diseases of the Fetus and Newborn Infant, 4th ed. Remington JS. Klein JO (Eds). WB Saunders, Philadelphia, 1995, pp 980–1054
- Goldschneider I, Gotschlich EC, Artenstein MS: Human immunity to the meningococcus. I: The role of humoral antibodies. J Exp Med 129:1307, 1969
- Käyhty H., Eskola J: New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis 2:289, 1996
- Krause RM: The elusive history of staphylococcal immunity: A search from mirage to reality. In The Staphylococci. Jeljaszewicz J, Ciborowski P (Eds). Gustav Fischer Verlag, New York. 1991, pp 3–11
- Musher DM et al: Antibody to capsular polysaccharides of Streptococcus pneumoniae: Prevalence, persistence, and response to revaccination. Cline Infect Dis 17:66, 1993
- Musher DM et al: Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med 45:57, 1997
- Robbins JB et al: Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: Impact on public health and implications for other polysaccharide-based vaccines. JAMA 276:1181, 1996